Cartesian Therapeutics Inc (RNAC)
Deferred Revenue
$0.00
Quarterly · Period ending: · USD
RNAC Deferred Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
RNAC FY Deferred Revenue ($3.02M → $0.00)
Annual deferred revenue
High-resolution chart · PNG
RNAC deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 2,311,000 | |
| 593,000 | |
| 53,883,000 | |
| 72,050,000 | |
| 1,674,000 | |
| 959,000 | |
| 787,000 | |
| 1,836,000 | |
| 1,313,000 | |
| 3,018,000 |